Vimarsana
Biggest News Aggregation in the World

Oncological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncological Sciences Today - Breaking & Trending Today

Study reveals new insights into immune system - Vimarsana News

Study reveals new insights into immune system

<p style="text-align:justify">Recent developments in cancer research have highlighted the vital role of the immune system, particularly in the notable successes of cancer immunotherapy. Now, a paradigm-shifting study&nbsp;led by researchers at the Icahn School of Medicine at Mount Sinai in New York in collaboration with the University of Helsinki and Massachusetts General Hospital sheds light on how variations in immune genetics influence lung cancer risk, potentially paving the way for enhanced prevention strategies and screening. The findings were described in the Februar...

Study Reveals New Insights Into Immune System Role in Lung Cancer Risk - Vimarsana News

Study Reveals New Insights Into Immune System Role in Lung Cancer Risk

Recent developments in cancer research have highlighted the vital role of the immune system, particularly in the notable successes of cancer immunotherapy. Now,

Professor of Biomedical Data Science (Assistant, Associate, and/or Professor Level) job with Oregon Health and Science University - Vimarsana News

Professor of Biomedical Data Science (Assistant, Associate, and/or Professor Level) job with Oregon Health and Science University

Professor of Biomedical Data Science (Assistant, Associate, and/or Professor Level) job in Portland, Oregon with Oregon Health and Science University. Apply Today.

Source: nature.com
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Upda - Vimarsana News

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Upda

- Total Revenues of $480 million for the Fourth Quarter of 2023, $1,830 million for the Fiscal Year 2023 -- Cabozantinib Franchise Achieved $1,629 million in U.S. Net Product Revenues for the Fiscal Year 2023, including $429 million for the Fourth Quarter of 2023 -- GAAP Diluted EPS of $0.27 for the Fourth Quarter o...

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update - Vimarsana News

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update

- Total Revenues of $480 million for the Fourth Quarter of 2023, $1,830 million for the Fiscal Year 2023 - - Cabozantinib Franchise Achieved $1,629 million in U.S. Net Product Revenues for the...